Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

OBJECTIVE: To describe the efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) or ankylosing spondylitis (AS) in a post-hoc analysis of randomised controlled trials. METHODS: Data were collected from patients in seven tofacitinib studies: si...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogdie, Alexis, de Vlam, Kurt, McInnes, Iain B, Mease, Philip J, Baer, Philip, Lukic, Tatjana, Gruben, David, Kwok, Kenneth, Wang, Cunshan, Hsu, Ming-Ann, Maniccia, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Pain
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999680/
https://www.ncbi.nlm.nih.gov/pubmed/32396519
http://dx.doi.org/10.1136/rmdopen-2019-001042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999680/
https://www.ncbi.nlm.nih.gov/pubmed/32396519
http://dx.doi.org/10.1136/rmdopen-2019-001042

Ejemplares similares